Filing Error
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Case #: | 1:19-op-46028 |
| Nature of Suit | 470 Other Statutes - Racketeer Influenced and Corrupt Organizations |
| Cause | 28:1441 Petition for Removal- Racketeering (RICO) |
| Case Filed: | Jan 23, 2019 |
| Terminated: | Jan 24, 2019 |
| Case in other court: | Louisiana Middle, 3:18-cv-01089 |
| Last checked: Friday Nov 08, 2019 7:07 PM EST |
|
Defendant
Johnson & Johnson
|
Represented By
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
Represented By
|
|
Defendant
Teva Pharmaceutical Industries Ltd.
|
Represented By
|
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
|
Defendant
Purdue Frederick Company, Inc.
|
Represented By
|
|
Defendant
Ortho-McNeil-Janssen Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Noramco Inc
|
|
|
Defendant
Morris and Dickson, Co., Inc.
|
|
|
Defendant
McKesson Corporation
|
Represented By
|
|
Defendant
Mallinckrodt PLC
|
|
|
Defendant
Mallinckrodt LLC
|
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Janssen Pharmaceutica Inc.
|
Represented By
|
|
Defendant
Insys Therapeutics Inc.
|
Represented By
|
|
Defendant
Endo Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Endo Health Solutions Inc.
|
Represented By
|
|
Defendant
Cephalon Inc.
|
Represented By
|
|
Defendant
Cardinal Health Inc.
|
Represented By
|
|
Defendant
AmerisourceBergen Drug Corporation
|
Represented By
|
|
Defendant
Allergan PLC
|
|
|
Defendant
Allergan Finance LLC
|
Represented By
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Plaintiff
City of Donaldsonville
|
Represented By
|
|
Plaintiff
Purdue Pharma Inc.
|
Represented By
|
| Docket last updated: 04/15/2019 9:14 AM EDT |
| Wednesday, December 19, 2018 | ||
| 1 | 1
NOTICE OF REMOVAL from 23rd JDC Parish of Ascension, Case Number 123834. (Filing fee $ 400 receipt number ALAMDC-1877437), filed by Teva Pharmaceuticals USA, Inc..(Crisler, Richard) [Transferred from lamd on 1/23/2019.]
|
|
|
Att: 1
Exhibit,
|
||
|
Att: 2
Exhibit,
|
||
|
Att: 3
Attachment Civil Cover Sheet,
|
||
|
Att: 4
Attachment Attorney List
|
||
| Thursday, December 20, 2018 | ||
| 2 | 2
Letter to JPML Panel notifying panel of possible JPML case (KAH) [Transferred from lamd on 1/23/2019.]
|
|
| 3 | 3
Corporate Disclosure Statement by Teva Pharmaceuticals USA, Inc. identifying Corporate Parent TEVA Pharmaceutical Industries, Ltd., Corporate Parent Teva Pharmaceuticals Holdings Cooperative U.A., Corporate Parent Orvet UK Unlimited, Corporate Parent IVAX LLC, Corporate Parent Teva Pharmaceuticals Europe B.V. for Teva Pharmaceuticals USA, Inc... (Crisler, Richard) [Transferred from lamd on 1/23/2019.]
|
|
| 4 | 4
NOTICE of Related Proceedings by Teva Pharmaceuticals USA, Inc. (Crisler, Richard) [Transferred from lamd on 1/23/2019.]
|
|
| Friday, December 21, 2018 | ||
| 5 | 5
NOTICE of Supplemental Notice of Removal by McKesson Corporation(Williams, Stacey) [Transferred from lamd on 1/23/2019.]
|
|
|
Att: 1
Exhibit
|
||
| 6 | 6
Corporate Disclosure Statement by McKesson Corporation (Williams, Stacey) [Transferred from lamd on 1/23/2019.]
|
|
| 7 | 7
NOTICE of Notice of Collateral Proceedings by McKesson Corporation (Williams, Stacey) [Transferred from lamd on 1/23/2019.]
|
|
| 8 | 8
Unopposed MOTION for Extension of Time Responsive Pleadings by AmerisourceBergen Drug Corporation, Cardinal Health, Inc, McKesson Corporation.(Williams, Stacey) [Transferred from lamd on 1/23/2019.]
|
|
|
Att: 1
Proposed Pleading;
|
||
| Wednesday, December 26, 2018 | ||
| MOTION(S) REFERRED:8 Unopposed MOTION for Extension of Time Responsive Pleadings. This motion is now pending before the USMJ. (ELW) [Transferred from lamd on 1/23/2019.] | ||
| 9 | 9
MOTION for Extension of Time to File Answer by Teva Pharmaceuticals USA, Inc..(Crisler, Richard) [Transferred from lamd on 1/23/2019.]
|
|
|
Att: 1
Attachment Proposed Order
|
||
| Thursday, December 27, 2018 | ||
| MOTION(S) REFERRED:9 MOTION for Extension of Time to File Answer . This motion is now pending before the USMJ. (KAH) [Transferred from lamd on 1/23/2019.] | ||
| Thursday, January 03, 2019 | ||
| 10 | 10
MOTION to Remand to State Court by City of Donaldsonville.(Leger, Walter) [Transferred from lamd on 1/23/2019.]
|
|
|
Att: 1
Memorandum in Support
|
||
| Friday, January 04, 2019 | ||
| MOTION(S) REFERRED:10 MOTION to Remand to State Court . This motion is now pending before the USMJ. (KAH) [Transferred from lamd on 1/23/2019.] | ||
| Monday, January 14, 2019 | ||
| MOTION(S) REFERRED:11 Consent MOTION to Continue Submission of Plaintiff's Motion to Remand . This motion is now pending before the USMJ. (NLT) [Transferred from lamd on 1/23/2019.] | ||
| 11 | 11
Consent MOTION to Continue Submission of Plaintiff's Motion to Remand by McKesson Corporation, Teva Pharmaceuticals USA, Inc..(Williams, Stacey) [Transferred from lamd on 1/23/2019.]
|
|
|
Att: 1
Proposed Pleading;
|
||
| Wednesday, January 16, 2019 | ||
| 12 | 12 ORDER granting8 Motion for Extension of Time to Move, Answer, or Otherwise Respond to the Complaint. MCKESSON CORPORATION, AMERISOURCEBERGEN DRUG CORPORATION and CARDINAL HEALTH, INC. shall have up to, through and including 60 days after the later of (1) this Courts ruling on any motion to remand, or (2) the Judicial Panel on Multidistrict Litigation enters a final order granting a motion to vacate the conditional transfer order or a final decision otherwise denying transfer to the MDL. Signed by Magistrate Judge Richard L. Bourgeois, Jr. on 1/16/2019. (This is a TEXT ENTRY ONLY. There is no hyperlink or PDF document associated with this entry.) (JSL) [Transferred from lamd on 1/23/2019.] | |
| 13 | 13 ORDER granting9 Motion for Extension of Time to Answer. Actavis LLC; Actavis Pharma, Inc.; Allergan Finance LLC; Allergan PLC; Cephalon, Inc.; Endo Health Solutions Inc.; Endo Pharmaceuticals, Inc.; INSYS Therapeutics, Inc. ; Janssen Pharmaceutica Inc.; Janssen Pharmaceuticals, Inc.; Johnson & Johnson ; Mallinckrodt LLC; Mallinckrodt PLC; Noramco, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Purdue Pharma L.P.; Purdue Pharma, Inc.; Teva Pharmaceutical Industries Ltd.; Teva Pharmaceuticals USA, Inc.; The Purdue Frederick Company, Inc.; Watson Laboratories, Inc. shall have up to, through and including 60 days after the later of (1) this Court's ruling on any motion to remand (2) the Judicial Panel on Multidistrict Litigation enters a final order granting a motion to vacate the conditional transfer order or a final decision otherwise denying transfer to the MDL to move, answer or otherwise respond to the Complaint. Signed by Magistrate Judge Richard L. Bourgeois, Jr. on 1/16/2019. (This is a TEXT ENTRY ONLY. There is no hyperlink or PDF document associated with this entry.) (JSL) [Transferred from lamd on 1/23/2019.] | |
| Tuesday, January 22, 2019 | ||
| 14 | 14
ORDER lifting the Stay of Conditional Transfer Order (CTO-73)(NLT) [Transferred from lamd on 1/23/2019.]
|
|
|
Att: 1
NEF from JPML Court,
|
||
|
Att: 2
Minute Order
|
||
| 15 | 15 ORDER granting11 Consent Motion to Continue. For good cause shown, briefing on the pending motion to remand is suspended. Counsel shall notify the undersigned if a briefing order is necessary should the JPML deny transfer. Signed by Magistrate Judge Richard L. Bourgeois, Jr. on 1/22/2019. (This is a TEXT ENTRY ONLY. There is no hyperlink or PDF document associated with this entry.) (Bourgeois, Richard) [Transferred from lamd on 1/23/2019.] | |
| Wednesday, January 23, 2019 | ||
| 16 | 16
Order Transferring Case to JPML Court.(NLT) [Transferred from lamd on 1/23/2019.]
|
|
|
Att: 1
JPML Order
|
||
| 17 | 17
CASE TRANSFERRED IN from District of Louisiana Middle. Case number 3:18-cv-01089. Original file, certified copy of transfer order and docket sheet received.
|
|